Document Detail


The state of the excimer laser for coronary intervention in the drug-eluting stent era.
MedLine Citation:
PMID:  23332778     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: This study aims to determine how excimer laser coronary atherectomy (ELCA) performs in the drug-eluting stent (DES) era. BACKGROUND: For more than 20years, ELCA has been used for coronary intervention. With developments in the coronary intervention field, the role of ELCA is in question. METHODS: The study includes 119 patients with 124 lesions who underwent percutaneous coronary intervention (PCI) with ELCA in our institution from January 2004 to May 2011. RESULTS: The main indications for ELCA use were saphenous vein graft (SVG) (45 lesions), acute myocardial infarction (AMI) (7 lesions), chronic total occlusion (CTO) (32 lesions), in-stent restenosis (ISR) (15 lesions), and calcified de-novo lesions (25 lesions). High success rates were recorded for the SVG, AMI, CTO, ISR, and calcified lesion indications (91.1%, 85.7%, 93.8%, 86.7%, and 80%; respectively). ELCA related complications were reported in 10 patients (8%); four dissections, three no-reflow phenomena, two perforations, and one thrombus formation. CONCLUSION: ELCA is an alternative solution with acceptable performance in the treatment of complex coronary lesions not ideally suitable for balloon angioplasty.
Authors:
Salem Badr; Itsik Ben-Dor; Danny Dvir; Israel M Barbash; Hironori Kitabata; Sa'ar Minha; Lakshmana K Pendyala; Joshua P Loh; Rebecca Torguson; Augusto D Pichard; Ron Waksman
Related Documents :
23510948 - Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ej...
24642828 - Transesophageal echocardiographic evaluation of left ventricular systolic and diastolic...
23910428 - Impact of hypertension on distal embolization, myocardial perfusion, and mortality in p...
18436918 - Inequity of access to investigation and effect on clinical outcomes: prognostic study o...
23485798 - Development and validation of a clinical risk score predicting the no-reflow phenomenon...
10901518 - Left main coronary artery stenosis: early experience with surgical revascularization wi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-16
Journal Detail:
Title:  Cardiovascular revascularization medicine : including molecular interventions     Volume:  -     ISSN:  1878-0938     ISO Abbreviation:  Cardiovasc Revasc Med     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101238551     Medline TA:  Cardiovasc Revasc Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Affiliation:
Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Global organization of functional brain connectivity in methamphetamine abusers.
Next Document:  Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function.